For Admin

  • HOME
  • BUSINESS
  • TECHNOLOGY
  • APPLICATION
  • PARTNERING
  • NEWS
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012〜
  • CONTACT

Shin Nippon Biomedical Laboratories, Ltd. Translational Research Business

Japanese

A Leading Company in Nasal Drug Delivery

  • HOME
  • BUSINESS
  • TECHNOLOGY
    • Platform Technology
    • Special Analysis
    • Publication
  • APPLICATION
    • Absorption
    • Vaccination
    • Nose-to-Brain
  • PARTNERING
  • NEWS
  • CONTACT
  • PRIVACY POLICY

Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

Widely Applicable Technology

For Absorption
For Vaccination
For Nose-to-Brain

Expertise in Nasal Delivery

3D Nasal Cast Model

preview
next

News

2012〜

December 26, 2012

μco™ System is featured in the December 2012 edition of ONdrugDelivery magazine.

November 13, 2012

Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Zolmitriptan for Migraine

October 10, 2012

μco™ System is featured in the September 2012 edition of ONdrugDelivery magazine.

June 7, 2012

SNBL's Fit-lizer™ device is featured in the June 2012 Edition of Drug Development & Delivery Magazine.

May 5, 2012

μco™ System is featured in the April 2012 edition of ONdrugDelivery magazine.

April 4, 2012

Results of First Phase I Clinical Study for Intranasal Zolmitriptan Formulation (Migraine Drug)

February 10, 2011

Conclusion of Licensing Agreement with Pastorus

August 19, 2010

Results of a Meeting with the US Food and Drug Administration (FDA) Concerning the Development of Intranasal Granisetron; Planning for a Phase 3 Study to Improve Patient Quality of Life (QOL)

August 11, 2010

Intranasal Zolmitriptan: Clinical Study of Rapid Acting Migraine Drug - Preparations Underway for US Phase 1 Clinical Study -

May 12, 2010

Research Progress on TR-Flu, an Intranasal Flu Vaccine in Dry Powder Form (First Report)

2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜

BACK
  • HOME
  • BUSINESS
  • TECHNOLOGY
  • APPLICATION
  • PARTNERING
  • NEWS
  • CONTACT
  • PRIVACY POLICY
Cookie Policy | Sitemap
© Shin Nippon Biomedical Laboratories, Ltd. All Rights Reserved.
Log out | Edit